<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-10-25T23:19:40+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://www.medicinanews.it/mappatura-prostata-tecnologie-diagnostiche/368992/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T19:39:10+02:00</news:publication_date><news:title>Mappatura precisa del tumore della prostata: le nuove tecnologie diagnostiche per stratificare il rischio</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/arbitri-no-profit-no-surprises-act-milioni/368989/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T18:39:12+02:00</news:publication_date><news:title>Gli arbitri indipendenti del No Surprises Act: come i mediatori sanitari accumulano milioni di dollari</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/divisione-salute-donne-nih-ricerca/368986/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T17:39:10+02:00</news:publication_date><news:title>La nuova divisione NIH sulla salute delle donne: come cambierà la ricerca medica</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/cancro-pancreatico-terapia-combinata-risultati/368983/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T15:38:08+02:00</news:publication_date><news:title>Cancro pancreatico avanzato: Tango Therapeutics riporta l&#8217;82% di risposta tumorale con la terapia combinata</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/disparita-genere-impianti-defibrillatore-spagna/368980/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T14:38:11+02:00</news:publication_date><news:title>Donne sottorappresentate negli impianti di defibrillatore in Spagna: il divario di genere nella cardiologia</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/morti-overdose-italia-usa-prevenzione/368977/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T13:38:09+02:00</news:publication_date><news:title>Overdose: negli Usa il calo continua, in Italia cresce l&#8217;allarme. Come la prevenzione fa la differenza</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/curcumina-infiammazione-bpco/368974/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T12:37:12+02:00</news:publication_date><news:title>Curcumina contro l&#8217;infiammazione nella BPCO: cosa dicono gli studi clinici sulle sue proprietà terapeutiche</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/car-t-autoimmune-sicurezza-bristol-myers-squibb/368971/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T11:37:10+02:00</news:publication_date><news:title>Morte durante trial CAR-T di Bristol Myers Squibb: come definire i confini della sicurezza nelle terapie cellulari</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/daraxonrasib-cancro-pancreas-metastatico/368968/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T10:37:38+02:00</news:publication_date><news:title>Daraxonrasib: i mesi di sopravvivenza guadagnati con il nuovo farmaco per il cancro al pancreas</news:title></news:news></url>
</urlset>
